The delivery of bronchodilators with metered-dose inhaler (MDI) in mechanic
ally ventilated patients has attracted considerable interest in recent year
s. This is because the use of the MDI has several advantages over the nebul
izer, such as reduced cost, ease of administration, less personnel time, re
liability of dosing and a lower risk of contamination. A spacer device is f
undamental in order to demonstrate the efficacy of the bronchodilatory ther
apy delivered by MDI. Provided that the technique of administration is appr
opriate, MDIs are as effective as nebulizers, despite a significantly lower
dose of bronchodilator given by the MDI.